Keyword: Herceptin

The treatment staved off cancer for a median of 16.4 months and shrank tumors in 61% of patients with HER2-positive breast cancer.

Bolt Biotherapeutics presented positive results from animal trials of its lead drug, a tumor-targeting antibody connected to an immune stimulator.

The anti-HER2 antibody improved PFS by more than Herceptin, teeing MacroGenics up to file for approval in the second half of the year.

Imugene says its HER2 vaccine hit the mark in a phase 1b trial, setting up a phase 2 study that will start recruiting patients in the new year.

The trial is assessing the use of technology for harvesting circulating tumor cells in combination with Abbott’s test of HER-2 status.

After a deal for Immunomedics fell through last May, Seattle Genetics has scaled down spending to ink a $614 million deal for Cascadian Therapeutics.

Swiss Big Pharma Roche has given Ignyta an early Christmas present in the form of a $1.7 billion buyout, worth $27 a share.

Mylan has filed for FDA approval of its biosimilar copy of Roche’s Herceptin, teeing it up to start chipping away at a cornerstone of the Big Pharma's business.

A month after Mylan and Biocon saw the EMA accept their marketing application for a copycat version of Roche’s major blockbuster cancer med Herceptin (trastuzumab)--the first to do so--Samsung Bioepis says it too has now notched that regulatory milestone as the companies race to market.

Fresh off a positive FDA panel earlier this month for what could be its first approved biosimilar for Humira, Amgen--and partner Allergan--have reported positive top-line Phase III data for its Herceptin biosimilar.